{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T05:01:38Z","timestamp":1789275698450,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170213"],"award-info":[{"award-number":["82170213"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370216"],"award-info":[{"award-number":["82370216"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82293634"],"award-info":[{"award-number":["82293634"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070190"],"award-info":[{"award-number":["82070190"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2500300-4"],"award-info":[{"award-number":["2021YFC2500300-4"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.lanwpc.2025.101664","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T08:42:35Z","timestamp":1754988155000},"page":"101664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Decitabine combined with reduced-intensity conditioning for older patients with acute myeloid leukemia in composite complete remission undergoing allogeneic hematopoietic stem cell transplantation: a multicenter, single-arm, phase 2 trial"],"prefix":"10.1016","volume":"61","author":[{"given":"Qifa","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongli","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guopan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangkun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6176-7411","authenticated-orcid":false,"given":"Li","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanwpc.2025.101664_bib1","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1158\/1078-0432.CCR-23-3673","article-title":"Improvements in posttransplant outcomes over two decades in older patients with acute myeloid leukemia in the EBMT ALWP study","volume":"30","author":"Bazarbachi","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lanwpc.2025.101664_bib2","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1200\/JCO.23.02631","article-title":"Risk stratification in older intensively treated patients with AML","volume":"42","author":"Versluis","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lanwpc.2025.101664_bib3","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1200\/JCO.2015.62.7273","volume":"33","author":"Devine","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lanwpc.2025.101664_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13045-018-0598-0","article-title":"Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT","volume":"11","author":"Santoro","year":"2018","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.lanwpc.2025.101664_bib5","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1038\/sj.leu.2403967","volume":"19","author":"Aoudjhane","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.lanwpc.2025.101664_bib6","doi-asserted-by":"crossref","first-page":"e555","DOI":"10.3324\/haematol.2018.214429","article-title":"Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial","volume":"104","author":"Mehta","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.lanwpc.2025.101664_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13045-016-0295-9","article-title":"The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years-a report from the EBMT acute leukemia working party","volume":"9","author":"Rubio","year":"2016","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.lanwpc.2025.101664_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","article-title":"Recent advances in targeted therapies in acute myeloid leukemia","volume":"16","author":"Bhansali","year":"2023","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.lanwpc.2025.101664_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.exphem.2018.08.002","article-title":"Epigenetic modification enhances the cytotoxicity of busulfan and4-hydroperoxycyclophosphamide in AML cells","volume":"67","author":"Valdez","year":"2018","journal-title":"Exp Hematol"},{"key":"10.1016\/j.lanwpc.2025.101664_bib10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.leukres.2009.08.014","article-title":"5-Aza-2'-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis","volume":"34","author":"Valdez","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.lanwpc.2025.101664_bib11","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/ajh.26903","article-title":"Conditioning therapy with N-acetyl-L-cysteine, decitabine and modified BUCY regimen for myeloid malignancies patients prior to allogeneic hematopoietic stem cell transplantation","volume":"98","author":"Tang","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.lanwpc.2025.101664_bib12","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1016\/S2352-3026(22)00375-1","volume":"10","author":"Xuan","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.lanwpc.2025.101664_bib13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1186\/s12916-024-03830-0","article-title":"Intensified conditioning containing decitabine versus standard myeloablative conditioning for adult patients with KMT2A-rearranged leukemia: a multicenter retrospective study","volume":"22","author":"Hu","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.lanwpc.2025.101664_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217264","article-title":"Consensus on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic haematopoietic stem cell transplantation in China: 2024 update","volume":"605","author":"Wang","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.lanwpc.2025.101664_bib15","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1007\/s00277-023-05500-2","article-title":"Efficacy of venetoclax combined with decitabine conditioning regimen for allogeneic hematopoietic stem cell transplantation in high-risk and elderly patients with myeloid neoplasms","volume":"102","author":"Zheng","year":"2023","journal-title":"Ann Hematol"},{"key":"10.1016\/j.lanwpc.2025.101664_bib16","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.lanwpc.2025.101664_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13045-020-00859-5","article-title":"Haploidentical versus HLA-matched sibling transplantation for refractory acute leukemia undergoing sequential intensified conditioning followed by DLI: an analysis from two prospective data","volume":"13","author":"Yu","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.lanwpc.2025.101664_bib18","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","article-title":"Regimen-related toxicity in patients undergoing bone marrow transplantation","volume":"6","author":"Bearman","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lanwpc.2025.101664_bib19","first-page":"825","article-title":"1994 Consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.lanwpc.2025.101664_bib20","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.lanwpc.2025.101664_bib21","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S1470-2045(20)30455-1","article-title":"Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial","volume":"21","author":"Xuan","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.lanwpc.2025.101664_bib22","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1200\/JCO.23.00101","article-title":"Busulfan plus fludarabine compared with busulfan plus cyclophosphamide for AML undergoing HLA-haploidentical hematopoietic cell transplantation: a multicenter randomized phase III trial","volume":"41","author":"Ling","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lanwpc.2025.101664_bib23","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1182\/bloodadvances.2021005566","article-title":"Adding venetoclax to fludarabine\/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active","volume":"5","author":"Garcia","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.lanwpc.2025.101664_bib24","doi-asserted-by":"crossref","first-page":"e879","DOI":"10.1016\/S2352-3026(23)00273-9","article-title":"10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial","volume":"10","author":"L\u00fcbbert","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.lanwpc.2025.101664_bib25","doi-asserted-by":"crossref","first-page":"E284","DOI":"10.1002\/ajh.24340","article-title":"Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older","volume":"91","author":"Konuma","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.lanwpc.2025.101664_bib26","doi-asserted-by":"crossref","first-page":"774.e1","DOI":"10.1016\/j.jtct.2021.05.024","article-title":"Comparable outcomes after alternative and matched sibling donor hematopoietic stem cell transplantation and the role of molecular measurable residual disease for acute myeloid leukemia in elderly patients","volume":"27","author":"Cho","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.lanwpc.2025.101664_bib27","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1200\/JCO.20.00150","article-title":"Antithymocyte globulin for matched sibling donor transplantation in patients with hematologic malignancies: a multicenter, open-label, randomized controlled study","volume":"38","author":"Chang","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lanwpc.2025.101664_bib28","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1182\/blood.2021014520","article-title":"Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML","volume":"139","author":"Murdock","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.lanwpc.2025.101664_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41408-022-00774-7","article-title":"Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML","volume":"13","author":"Tsai","year":"2023","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.lanwpc.2025.101664_bib30","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3324\/haematol.2016.143073","article-title":"Clinical characteristics and prognosis of acute myeloid leukemia associated with DNA-methylation regulatory gene mutations","volume":"101","author":"Ryotokuji","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.lanwpc.2025.101664_bib31","doi-asserted-by":"crossref","first-page":"479.e1","DOI":"10.1016\/j.jtct.2021.02.028","article-title":"Outcomes for patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation","volume":"27","author":"Chen","year":"2021","journal-title":"Transplant Cell Ther"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606525002032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606525002032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T21:32:04Z","timestamp":1772919124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606525002032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":31,"alternative-id":["S2666606525002032"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2025.101664","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decitabine combined with reduced-intensity conditioning for older patients with acute myeloid leukemia in composite complete remission undergoing allogeneic hematopoietic stem cell transplantation: a multicenter, single-arm, phase 2 trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2025.101664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101664"}}